Intravenous Exenatide in Patients With Acute Brain Injury

Completed · Phase 4

Conditions studied: Brain Injuries

In brief

The purpose of this study is to assess the feasibility of exenatide infusion for the treatment of high blood sugars following acute brain injury.

Key facts

Study ID
NCT02058940
Run by
University of North Carolina, Chapel Hill
People needed
8
Starts
2015-08-01
Expected to finish
2017-08-01
Last updated by the study team
2018-07-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.